Phenotypic properties influencing HIV-1 transmission fitness IAS Conference on HIV Pathogenesis, Treatment & Prevention Vancouver July 21 st 2015 Katja.

Slides:



Advertisements
Similar presentations
Emerging patterns of drug resistance and viral tropism in cART-naïve and failing patients infected with HIV-1 subtype C Thumbi Ndung’u, BVM, PhD Associate.
Advertisements

Evoluzione genetica di HIV ed evoluzione clinica della malattia AIDS: due aspetti correlati? Carlo Federico Perno.
Purging the HIV-1 Reservoir Through the Disruption of the PD-1 Pathway
Office of Infectious Diseases Computational Challenges for Infectious Diseases Michael Shaw, PhD OID/Office of the Director.
Antiviral Immunity and Transmission June 19, 2011 Abst. #: TUAA0105 Maraviroc-resistant subtype B primary HIV-1 induced in vitro selection became highly.
HIV-1 escape from the CCR5 antagonist maraviroc associated with an altered and less efficient mechanism of gp-120 CCR5 engagement that attenuates macrophage.
 Longitudinal analysis of mucosal immune quiescence and impact of commercial sex work in HIV Exposed Seronegative (HESN) sex workers from Nairobi, Kenya.
Interactive Workshop “HIV Cure 101”: Challenges in identifying and targeting the HIV reservoir Sarah Palmer Centre for Virus Research Westmead Millennium.
Topical oestrogen induces keratinisation of human inner foreskin whilst Langerhans cell distribution remains unaffected – implications for HIV prevention.
Designing and Optimizing an Adenovirus Encoded VLP Vaccine against HIV Anne-Marie Andersson PhD Student, University of Copenhagen.
Immunity to Infectious Diseases BIOS 486A/586A K.J.Goodrum 2006.
Analysis of Genetic Linkage of HIV from Couples Enrolled in the HPTN 052 Trial Susan H. Eshleman, MD/PhD HPTN Network Laboratory Johns Hopkins Univ. School.
Introduction to viruses
Defenses Against Infection 1. Innate responses (humoral and cellular) 2. Immunity to intracellular pathogens NK cells, control of Th1/Th2 responses 3.
In vivo analysis of HIV replication and persistence in the myeloid compartment J. Honeycutt, A. Wahl, J. Foster, R.A. Spagnulo and J. Victor Garcia Division.
Fig 1: HIV-1/HCV and HIV-1/HBV Co-Infection/Co- Culture Systems Philippe A. Gallay 1, Udayan Chatterji 1, Michael Bobardt 1, Daren Ure 2, Dan Trepanier.
The Role of Mast Cells and CD117 in the Spread of HIV-1 Particles in Vitro Stacey Baker, Department of Biology, York College Project Summary Little is.
Strategies for Targeting and Eradicating the HIV Reservoir
DNA methylation as an epigenetic marker in HIV-2 disease in West Africa? Alberta Davis MRC Laboratories, Gambia 18th January 2013.
Pathogenesis of HIV disease and markers of progression Anjie Zhen, PhD.
Replication capacities of chimeric NL4-3 encoding gag-protease from recent HIV-1 isolates are significantly reduced compared to those derived from isolates.
Autologous T-cell therapy based on a lentiviral vector expressing long antisense RNA targeted against HIV-1 env gene influences HIV replication and evolution.
The Influence of CCL3L1 Gene- Containing Segmental Duplications on HIV-1/AIDS Susceptibility Gonzalez et al. Mar 4, 2005 :307 Science Presenter: Braydon.
Characteristics of transmitted viruses in acute and early HIV infection Eric Hunter IAC 2010.
HIV-1 evolution in response to immune selection pressures
HIV Cellular Pathogenesis III
Toll-Like Receptors in CNS Viral Infections Unclear role of TLRs in natural infections TLR3, -7, -8, -9 recognize viral nucleic acids. Localized intracellularly.
Studies of HIV Eradication: a Case for Using NHP Models Guido Silvestri, MD Yerkes National Primate Research Center Emory University School of Medicine.
CCR5 Monoclonal Antibody PRO 140 Inhibited HIV-1 Resistant to Maraviroc, a Small Molecule CCR5 Antagonist Andre J Marozsan Progenics Pharmaceuticals, Inc.
Viral Tissue Reservoirs Are Determined Early and Little Viral RNA Is Detected during Suppression in the Macaque Model Zandrea Ambrose, Ph.D. Division of.
Innate Immunity Innate immunity is an evolutionary ancient form of host defense that serves to limit infection from the 1st minutes to hours after exposure.
Immunology of HIV Infection Michael F. Para, MD Professor of Internal Medicine Division of Infectious Diseases 1 1.
Primary HIV-1 Infection Pathogenesis, Diagnosis, and Treatment Summary of Evidence Martin Markowitz M.D. Clinical Director and Staff Investigator Aaron.
Cyanovirin-N A sugar-binding antiviral protein Christian García Blanca Arroyo.
Determinants of HIV Transmission Eric Hunter Emory Vaccine Center.
HIV Cellular Pathogenesis III Benhur Lee, M.D.. Adult v. infant (IgG v. IgA) CTL response (MHC tetramers) p24 antigenimia Ab response Viral load.
P1 Virology, Pathogenesis And Treatment Of HIV Infection.
Future directions in HIV basic science research The hunt for a cure.
Immune System.
HIV-1 infection decreases CD127 and PD1 expression on duodenal CD8+T cells Liliana Belmonte, PhD Academia Nacional de Medicina Buenos Aires, Argentina.
The mechanism of HCV extrahepatic infection
1 Molecular Mechanisms for gp160-Enhanced Apoptosis Keith J. Micoli, Olga A. Mamaeva, George Pan, Eric Hunter and Jay M. McDonald University of Alabama.
ImmunoPathogenesis of HIV Disease Overview of HIV Epidemic Basic biology of HIV-1 Stages of HIV Disease Viral and Cellular Dynamics after HAART HIV Therapy.
A single dose of an HIV-specific, vaginally-applied microbicide, PSC- RANTES (PSC) can select for a drug resistant SHIV in a macaque model Dawn Moore-Dudley.
Acquired Immunodeficiency Syndrome AIDS
Susan L. Uprichard, PhD Director of Hepatology Research Loyola University Medical Center Department of Medicine Section of Hepatology HepNet 2013 HCV Virology.
HIV pathogenesis The course of HIV infection 1. Acute Phase 2. Intermediate (asymptomatic) phase -viral load stabilizes at a “set point”. 3. Late (symptomatic)
Conclusions Modulation of Mucosal Transmission Oral Poster Session.
25 Years of HIV Vaccine Research: What have we accomplished? José Esparza MD, PhD Senior Advisor on HIV Vaccines Global Health Program The Search for an.
ROLE OF CCR5 LEVELS IN HIV-1 EVOLUTION AND PATHOGENESIS ANJALI JOSHI Assistant Professor Center of Emphasis in Infectious Diseases Department of Biomedical.
CATEGORY: VACCINES & THERAPEUTICS HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK HIV-1 Vaccines © The copyright for this work resides.
HIV & Influenza Figure 2 | Schematic diagram of HIV‑1 and influenza A virus. Both HIV-1 and influenza A virus are approximately 80–120 nm in diameter and.
Impact of immune-driven sequence variation in HIV- 1 subtype C Gag-protease on viral fitness and clinical outcome Thumbi Ndung’u, BVM, PhD HIV Pathogenesis.
Infection with subtype C HIV-1 of lower replicative fitness as compared to subtypes A and D leads to slower disease progression in Zimbabwean and Ugandan.
Diseases. Variations  Disease- a disorder of a body, system, organ structure or function. Ex. Christmas Disease (hemophilia B)  Virus- any member of.
Journal Club Presentation BIOL368/F16: Bioinformatics Laboratory
HIV-1 Vaccines Shokouh Makvandi-Nejad, University of Oxford, UK
Center for Biomedical Research
Immunodeficiency (2 of 2)
Immune System Chapter 14.
Monique Nijhuis University Medical Center Utrecht, the Netherlands
HIV Immunology Goes Out On a Limb
Structure of V3-containing HIV-1 gp120 core
Immunodeficiency (2 of 2)
The Rational Design of an AIDS Vaccine
HIV-Host Interactions: Implications for Vaccine Design
Volume 12, Issue 10, Pages (September 2015)
Volume 12, Issue 10, Pages (September 2015)
From Vaccines to Memory and Back
Centers for Disease Control and Prevention guidelines for evaluating the risk of HIV transmission after occupational exposure (PEP, post-exposure prophylaxis).
Presentation transcript:

Phenotypic properties influencing HIV-1 transmission fitness IAS Conference on HIV Pathogenesis, Treatment & Prevention Vancouver July 21 st 2015 Katja Klein U I have no conflict of interest to disclose.

Primary HIV-1 infection Primary HIV-1 infection requires the penetration of the virus across the mucosal barrier and the establishment of infection in target cells. In the vast majority of cases, mucosal HIV infection is initiated by a single infectious virus or a small number of HIV-1 virions. To better understand the infectious process, we need an in-depth comprehension of the phenotypes of transmitted viruses and how it contributes to the genetic bottleneck selection process. U Donor Recipient

Study Aim To explore transmission fitness and analyse possible phenotypic differences between acute and chronic HIV-1 that may effect the genetic bottleneck selection process. Find if there is an advantage of the virus that gets through the mucosal barrier and establishes a systemic infection. U

Acute and chronic viruses used in this study Constructed Env-chimeric viruses from: Eleven acute subtype B envelopes received from the Center for HIV/AIDS Vaccine Immunology (CHAVI, USA). Chronic subtype B envelopes from the Institute of Tropical Medicine (Belgium). Env-chimeras were generated by yeast-based cloning of the env gene into NL4-3 backbone at Case Western Reserve University (USA). Assays performed: Replication efficiency Sensitivity to entry inhibitors Entry kinetics Entry efficiency Transmission fitness U

Phenotypic analysis of acute and chronic HIV A.A. B.B. King et al JVI U Replication fitness in PBMCs by competing each of the acute virus against three chronic viruses. Test for differential sensitivity to entry inhibitors. Entry kinetics: Analyse how long it takes for the virus to get into the host cell. Entry efficiency in affinophile cells with variable CCR5 and CD4 expression. Replication kinetics in different cell types No selective advantage of acute over chronic viruses.

HIV-1 competitions in explant tissue; surrogate for “transmission” fitness U HIV-1 competitions: Mix 4-5 acute viruses + 3 chronic viruses Acute viruses compete in every possible combination →“round robin” B1, B2, B3, B4+ Q0, K44, I10 B4, B7, B8, B9+ Q0, K44, I10 B9, B14, B17, B19+ Q0, K44, I10 B19, B20, B2, B7+ Q0, K44, I10 B2, B7, B17+ Q0, K44, I10 B14, B20, B3, B8, B17 + Q0, K44, I10 B9, B20, B1, B7+ Q0, K44, I10 B1, B8, B4, B19 + Q0, K44, I10 …… Acute Chronic Acute: B1, B2, B3, B4, B7, B8, B9, B14, B17, B19, B20 Chronic: Q0, K44, I10

“transmission” fitness U

Acute vs chronic HIV-1 competition in cervical tissue U Percent replication in tissue Percent replication in MC + PM-1 cells chronic virus Cervix

Acute vs chronic HIV-1 competition in penile tissue U Penis Percent replication in tissue Percent replication in MC + PM-1 cells chronic virus

Summary of transmission fitness in mixed virus infections of penile tissue U

Accumulative analysis of mixed virus infections of penile tissue U

Potential influence of lectins on the infection process U Extracellular mannose binding lectins/proteins (MBL/Ps) and C-type lectins on epithelial cells bind and trap pathogens with high mannose, branched oligosaccharides. Mannose receptors on vaginal epithelial cells are thought limit pathogen infections and may even induce MBPs upon direct pathogen binding. Homozygote carriers for a variant MBL allele that decreases MBL concentrations (nearly 1000-fold in sera) were at high risk for HIV infection whereas heterozygotes showed slower disease progression. (Garred, P. et al. Lancet. 1997)

Role of Env glycosylation on transmission fitness U Daniel Stieh

Conserved N-linked glycosylation sites in HIV-1 Env U

Primary infection in the cervix vs blood >100 Ugandan and >180 Zimbabwean women were recruited within 3 months of infection U

Conclusion HIV-1 genetic diversity may be higher at the site of infection (e.g. vaginal tract) than in the plasma at acute/early infection. In our ex vivo models, chronic HIV-1 isolates appear to be “trapped and replicating” in the mucosal tissue whereas acute HIV-1 preferentially pass through the mucosal tissue via LC/DCs and are transmitted to T cells. Higher transmission fitness of acute HIV-1 correlates with reduced envelope N- linked glycosylation.  High levels of extracellular soluble lectins in tissue and C-type lectins expressed on epithelial cells are thought to prevent infection of high mannose-containing pathogens. As such, HIV-1 with reduced glycan shield may be passively selected for transmission by escaping the “lectin trap” due to reduced binding ability. U

Acknowledgements UCLA Samantha Johnston Sandra Nguyen Benhur Lee Imperial College Deborah King Asna Siddiqui Viviana Buffa Lucia Fishetti Robin J. Shattock CHAVI Investigators/Leaders Norman Letvin Joe Sodroski John Kappes Christina Jambor Brandon Keale Beatrice Hahn George Shaw Jeff Anderson Carolyn Williamson Ron Swanstrom and others…. University of Manchester John Archer David Robertson U R01 AI49170 University of Western Ontario/ Case Western Reserve University Eric Arts Awet Abraha Denis Tebit Yong Gao Michael Lobritz Kara Lassen Annette Ratcliff Immaculate Nankya Gabriele Nickel Kenneth Henry